Article: Dana-Farber Cancer Institute Extends Value of Clinical and Research Data With Oracle.

Oracle(R) Healthcare Transaction Base and Oracle Fusion Middleware Form Foundation for Translational Research Infrastructure Created to Improve Disease Understanding and Treatment

REDWOOD SHORES, Calif., Aug. 4 /PRNewswire-FirstCall/ -- -- Dana-Farber Cancer Institute, one of the leading cancer research and care centers in the United States, is using Oracle(R) Healthcare Transaction Base (HTB) and Oracle Fusion Middleware components as the foundation for its new translational research infrastructure.

-- The new infrastructure is designed to maximize the value of clinical and research data, and help improve disease understanding and patient care.

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!